Langzeitbehandlung einer patientin mit präeklampsie und HELLP-syndrom in einer sehr frühen schwangerschaftswoche

Translated title of the contribution: Long-term corticosteroid treatment of a patient with preeclampsia and HELLP syndrome in mid-pregnancy

S. Djalali, R. Axt-Fliedner, J. Spiegler, K. Diedrich, D. Hornung*

*Corresponding author for this work

Abstract

BACKGROUND: Hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome is associated with a high risk of serious maternal and neonatal morbidity and mortality. To date, termination of the pregnancy has been the appropriate treatment for this syndrome. However, long-term administration of corticosteroids is becoming increasingly popular for the treatment of HELLP syndrome. CASE REPORT: A 32-year-old primigravida was admitted to our hospital with HELLP syndrome in the 23rd week of gestation. The patient received corticosteroids for about six weeks. We achieved a successful prolongation of the patient's pregnancy until the 29th week of gestation. CONCLUSION: This case report supports the use of long-term corticosteriod administration for successful prolongation of a pregnancy in a patient with HELLP syndrome during early pregnancy.

Translated title of the contributionLong-term corticosteroid treatment of a patient with preeclampsia and HELLP syndrome in mid-pregnancy
Original languageGerman
JournalGeburtshilfe und Frauenheilkunde
Volume69
Issue number6
Pages (from-to)545-548
Number of pages4
ISSN0016-5751
DOIs
Publication statusPublished - 2009

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Long-term corticosteroid treatment of a patient with preeclampsia and HELLP syndrome in mid-pregnancy'. Together they form a unique fingerprint.

Cite this